Page 81 - Immunization Practices News Today

The panelists discuss the evolution of the pneumococcal vaccine landscape.

The Food and Drug Administration (FDA) has approved a drug to help protect infants from respiratory syncytial virus (RSV).

A recent report published in Morbidity and Mortality Weekly Report provided clinical guidance on Respiratory syncytial virus (RSV) vaccines for adults ≥60 years.

"I was literally suspended from Twitter for predicting this"

Vaccines often take years, and sometimes even decades, to develop, test, and approve for public use.

This Medical News story discusses the updated COVID-19 vaccines expected in the US this fall.

A new year means changes to Medicare, including updated premiums and deductibles and sometimes big policy moves. In 2023, theres a little of everything: Some costs have gone down, others

Social media users are sharing a post that juxtaposes rising autism rates with increases in the number of vaccines recommended for American children, implying a correlation. But the association is spurious; research shows vaccination does not cause autism, and experts say more cases are detected primarily due to higher awareness and better identification.

Most respiratory syncytial virus (RSV) cases occur among older age groups and the risk for hospitalization and death goes up by age. A new CDC report will help those making decisions about vaccination.

A key advisory group from the Centers for Disease Control and Prevention meets Monday to consider booster coverage of Covid-19 vaccines for all eligible